MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/ajh.21504

Медицинская библиотека · American journal of hematology · 2009

Outcome of 122 pregnancies in essential thrombocythemia patients: A report from the Italian registry.

Melillo Lorella, Tieghi Alessia, Candoni Anna, Radaelli Franca, Ciancia Rosanna, Specchia Giorgina, Martino Bruno, Scalzulli Potito Rosario, Latagliata Roberto, Palmieri Fausto, Usala Emilio, Valente Daniela, Valvano Maria Rosa, Cedrone Michele, Comitini Giuseppina, Martinelli Vincenzo, Cascavilla Nicola, Gugliotta Luigi

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Pregnancy is a high-risk event in women with essential thrombocythemia (ET). This observational study evaluated pregnancy outcome in ET patients focusing on the potential impact of aspirin (ASA) or interferon alpha (IFN) treatment during pregnancy. We retrospectively analyzed 122 pregnancies in 92 women consecutively observed in the last 10 years in 17 centers of the Italian thrombocythemia registry (RIT). The live birth rate was 75.4% (92/122 pregnancies). The risk of spontaneous abortion was 2.5-fold higher than in the control population (P < 0.01). ASA did not affect the live birth rate (71/93, 76.3% vs. 21/29, 72.4%, P = 0.67). However, IFN treatment during pregnancy was associated with a better outcome than was management without IFN (live births 19/20, 95% vs. 73/102, 71.6%, P = 0.025), and this finding was supported by multivariate analysis (OR: 0.10; 95% CI: 0.013-0.846, P = 0.034). The JAK2 V617F mutation was associated with a poorer outcome (fetal losses JAK2 V617F positive 9/25, 36% vs. wild type 2/24, 8.3%, P = 0.037), and this association was still significant after multivariate analysis (OR: 6.19; 95% CI: 1.17-32.61; P = 0.038). No outcome concordance between first and second pregnancies was found (P = 0.30). Maternal complications occurred in 8% of cases. In this retrospective study, in consecutively observed pregnant ET patients, IFN treatment was associated with a higher live birth rate, while ASA treatment was not. In addition, the JAK2 V617F mutation was confirmed to be an adverse prognostic factor.

Для цитирования: Melillo Lorella, Tieghi Alessia, Candoni Anna, Radaelli Franca, Ciancia Rosanna, Specchia Giorgina, Martino Bruno, Scalzulli Potito Rosario, Latagliata Roberto, Palmieri Fausto, Usala Emilio, Valente Daniela, Valvano Maria Rosa, Cedrone Michele, Comitini Giuseppina, Martinelli Vincenzo, Cascavilla Nicola, Gugliotta Luigi. Outcome of 122 pregnancies in essential thrombocythemia patients: A report from the Italian registry.. American journal of hematology. 2009. DOI: 10.1002/ajh.21504.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.